M&T Bank Corp Bridge Bio Pharma, Inc. Transaction History

M&T Bank Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$55.47 - $72.35 $295,044 - $384,829	-5,319 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$38.38 - $71.11 $35,731 - $66,203	-931 Reduced 14.9%	5,319 $378,000
Q2 2020 Jul 29, 2020	BUY	$22.22 - $35.69 $138,875 - $223,062	6,250 New	6,250 $204,000
Q1 2020 May 14, 2020	SELL	$16.11 - $36.23 $112,770 - $253,609	-7,000 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$17.96 - $46.63 $125,720 - $326,410	7,000 New	7,000 $245,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.